As a result, ABCB1- and ABCG2-overexpression CRC cells showed weak responses to gedatolisib, indicating that overexpression of ABCB1 and ABCG2 might be a key factor responsible for gedatolisib resistance. Here, ABCB1 is linked to colorectal carcinoma.